Eterna Therapeutics Inc. (ERNA)
Largest Insider Buys in Sector
ERNA Stock Price History Chart
ERNA Stock Performance
About Eterna Therapeutics Inc.
Brooklyn ImmunoTherapeutics, Inc., a clinical stage biopharmaceutical company, engages in developing therapies to treat patients with cancer. Its advanced program is IRX-2 that is in a Phase 2b clinical trial in patients with squamous cell cancer of the head and neck. The company also develops therapies using gene-editing and cell therapy technology for the treatment of oncology, blood disorder, and monogenic disease. Brooklyn ImmunoTherapeutics, Inc. is based in Brooklyn, New York.
Insider Activity of Eterna Therapeutics Inc.
Over the last 12 months, insiders at Eterna Therapeutics Inc. have bought $0 and sold $0 worth of Eterna Therapeutics Inc. stock.
On average, over the past 5 years, insiders at Eterna Therapeutics Inc. have bought $10,666.49B and sold $4.77M worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 13,252,112 shares for transaction amount of $31,999.46B was made by Cherington Charles (10 percent owner) on 2024‑10‑29.
List of Insider Buy and Sell Transactions, Eterna Therapeutics Inc.
| 2024-10-29 | 10 percent owner | 13.25M – | $2.41M | $31,999.46B | -52.73% | |||
| 2022-12-02 | director | 261,756 3.9322% | $3.28 | $858,560 | -16.36% | |||
| 2022-12-02 | director | 335,920 5.0463% | $3.28 | $1.1M | -16.36% | |||
| 2022-12-02 | director | 283,286 4.2556% | $3.28 | $929,178 | -16.36% | |||
| 2021-07-14 | 10 percent owner | 1 <0.0001% | $11.99 | $12 | -69.43% | |||
| 2021-07-09 | 10 percent owner | 1 <0.0001% | $14.11 | $14 | -70.12% | |||
| 2021-07-08 | 10 percent owner | 1 <0.0001% | $14.35 | $14 | -71.92% | |||
| 2021-07-06 | Sale | 10 percent owner | 75,000 5.5174% | $16.06 | $1.2M | -73.58% | ||
| 2021-06-17 | Sale | 200,000 14.426% | $15.75 | $3.15M | -67.47% | |||
| 2021-06-16 | Sale | 200,000 14.412% | $15.73 | $3.15M | -67.72% | |||
| 2020-08-13 | Sale | 10 percent owner | 327,650 8.3217% | $5.55 | $1.82M | -26.35% | ||
| 2020-06-17 | Sale | 10 percent owner | 12,400 0.3413% | $6.01 | $74,524 | -5.23% | ||
| 2020-06-16 | Sale | 10 percent owner | 100 0.0018% | $3.86 | $386 | -49.67% | ||
| 2020-06-03 | Sale | 10 percent owner | 21,932 0.1102% | $1.10 | $24,059 | +83.75% | ||
| 2020-06-02 | Sale | 10 percent owner | 30,730 0.1393% | $0.99 | $30,423 | +131.05% | ||
| 2020-06-01 | Sale | 10 percent owner | 30,000 0.1455% | $1.06 | $31,770 | +104.67% | ||
| 2020-05-29 | Sale | 10 percent owner | 25,000 0.1211% | $1.06 | $26,450 | +95.09% | ||
| 2020-05-28 | Sale | 10 percent owner | 12,338 0.0611% | $1.08 | $13,350 | +107.62% | ||
| 2020-05-27 | Sale | 10 percent owner | 5,000 0.0254% | $1.11 | $5,540 | +96.40% | ||
| 2020-05-26 | Sale | 10 percent owner | 20,000 0.0998% | $1.09 | $21,780 | +102.80% |
Insider Historical Profitability
| BROADWOOD PARTNERS, L.P. | 29971561 58.3391% | $0.25 | 15 | 0 | ||
| BRADSHER NEAL C | 9322262 18.1456% | $0.25 | 3 | 0 | ||
| Trinad Capital Master Fund Ltd. | 10 percent owner | 8900093 17.3239% | $0.25 | 41 | 0 | |
| WEST MICHAEL D | Co-Chief Executive Officer | 882864 1.7185% | $0.25 | 3 | 1 | |
| Cherington Charles | director | 556465 1.0831% | $0.25 | 1 | 2 | <0.0001% |